Women with large breast tissues may have a more significant risk for diagnostic ionising radiation-induced breast cancer!

 The topic of breast cancer and its associated risks is a key important area of concern for women's health. A recent review conducted by GOV.UK has thorough coverage of a common aspect of breast cancer risk with a focus on the impact of radiation and breast screening. The study expresses the potential correlation between breast size and the risk of radiation-induced breast cancer, offering biennial breast screening between 50 and 74 years!

In the context of the NHS Breast Screening Programme (NHSBSP) in England, the review evaluated the risks and benefits associated with digital breast screening, framing the discussion around the number of deaths linked to radiation-induced cancers and the lives saved as a result of the screening initiative.

This assessment used a radiation risk model, patient dose data, and UK screening statistics to estimate the impact of radiation-induced breast cancers within the program in the NHSBSP in England.

It's key to acknowledge the complexities involved in the process of breast screening.

The NHSBSP invites women for screening every three years, beginning from the age of 50 up to their 71st birthday.

During these screenings, digital mammography is used to acquire two views of both breasts.

This is where the correlation between breast size and radiation risk becomes analysed, as the exposure to ionising radiation during the mammography raises interesting considerations.

The review also takes into account the historical context, highlighting the differences between previous assumptions and current practices.

Notably, the report points out that in the past, 2D mammography was exclusively performed at the initial screen, with subsequent screenings often resorting to one-view mammography.

However, with the evolution of technology and practices, the variability of ionising radiation dose from screening and frequency of screenings have impacted, shaping the landscape of radiation-induced breast cancer incidence and mortality.

The study underlines the significance of screening in reducing breast cancer mortality, and the possible lives saved due to the advanced screening initiative. Therefore, it's crucial to balance the risks and benefits in the context of the more comprehensive healthcare landscape.

One of the thought-provoking disclosures from the study points towards the potential heightened risk for radiation-induced breast cancer among women with large breasts.

The data projected that women needing extra views for a full breast examination—comprising around 8% of the population—may face a higher incidence of radiation-induced breast cancer and mortality than their counterparts with small or average breasts.

It's important to emphasise that while these findings may raise concerns, the overall benefits of breast screening should not be ignored.

This context from reliable sources of breast cancer risk and its potential relations with breast size calls for continued discussion and further research.

These insights drive the need for a comprehensive approach to breast screening, one that not only believes in the benefits but also addresses the potential risks associated with radiation-induced breast cancer, particularly in women with large breasts.

Did you know that exposure to ionising radiation from repeated mammography examinations may actually increase the risk of breast cancer? It's rather scary.

While it's true that mammography is an effective screening tool for detecting breast cancer early, studies have shown that the radiation from these examinations can potentially contribute to the development of the disease.

Now, before you start worrying, it's important to note that the incidence and mortality of radiation-induced breast cancer associated with recommended screening strategies is believed to be low compared to the number of breast cancer deaths that are prevented through early detection.

However, it's still something that needs to be considered when evaluating screening programs.

One thing to keep in mind is that mammography can lead to false-positive recalls, which often result in additional diagnostic work-up and imaging.

This means that women may undergo more mammograms, biopsies, and follow-up examinations, all of which expose them to more radiation.

Not only that but obese women and women with dense breast tissue are more likely to undergo these additional evaluations, which increases their risk of radiation-induced cancer even further.

But here's where things get interesting.

There's a new technology called the Koning Vera Breast CT system that aims to reduce radiation exposure during breast imaging.

Koning breast CT medical device is FDA-approved, and is designed to limit X-ray exposure to the breast, making it comparable to a diagnostic mammogram in terms of radiation dose. The radiation dose from the device is even half that of stereotactic biopsies.

Additionally, there's another option called cone-beam breast computed tomography (CBBCT) which provides a lower radiation dose than traditional diagnostic mammography. The average radiation dose for CBBCT is 9.4 mGy, compared to 16.9 mGy for diagnostic mammography.

These innovations in breast screening are promising because they offer a way to minimise radiation exposure while still effectively detecting breast cancer less than 2mm.

Reducing the risks associated with repeated mammography examinations is compression-free, and detects stage 0 to 1 stage cancer with a 360-degree scanning angle. So women get better screening outcomes when undergoing breast cancer screenings.

So, while it's important to continue with regular breast cancer screenings, it's good to know that researchers and scientists are actively working on finding safer alternatives that can help reduce the risks associated with radiation exposure.

Stay tuned for more updates in the field of breast imaging and cancer detection!